Cathepsin A inhibitor (Neuropore Therapies)

N/A

Report date: 2024/11/04 15:47:34
NME

Base Information

Drug NameCathepsin A inhibitor (Neuropore Therapies)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin A inhibitors
TargetsCathepsin A
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuropore Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuropore Therapies Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A